DU145
Resource Report
Resource Website
1000+ mentions
|
RRID:CVCL_0105
|
Homo sapiens (Human)
|
Prostate carcinoma
|
Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: JFCR39 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:631930 PMID:1574572 PMID:1873816 PMID:2744886 PMID:3335022 PMID:3518877 PMID:6244232 PMID:6935474 PMID:7017212 PMID:8104329 PMID:8510267 PMID:8612713 PMID:9018337 PMID:9214606 PMID:9331090 PMID:9460501 PMID:10700174 PMID:10702678 PMID:10972993 PMID:11135431 PMID:11172901 PMID:11280753 PMID:11304728 PMID:11414198 PMID:11416159 PMID:12606952 PMID:12615715 PMID:12725112 PMID:14518029 PMID:15486987 PMID:15748285 PMID:17088437 PMID:17254797 PMID:17440963 PMID:19372543 PMID:20164919 PMID:22068913 PMID:22275356 PMID:22336246 PMID:22347499 PMID:22384151 PMID:22460905 PMID:22628656 PMID:23671654 PMID:23856246 PMID:23933261 PMID:23957452 PMID:24279929 PMID:24670534 PMID:25485619 PMID:25877200 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27377824 PMID:27397505 PMID:27807467 PMID:28196595 PMID:30244336 PMID:30629668 PMID:30787054 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31395879 PMID:31733513 PMID:31978347 PMID:35839778 PMID:38861359 PMID:38892296
|
Cancer cell line
|
Male |
DU-145, Du-145, DU 145, DU_145, DU.145, Duke University 145 |
|
|
BTO:BTO_0001332, CLO:CLO_0002840, CLO:CLO_0051536, EFO:EFO_0005441, MCCL:MCC:0000140, CLDB:cl1108, CLDB:cl1109, CLDB:cl4961, CLDB:cl5184, AddexBio:C0019004/4984, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:HTB-81, BCRC:60348, BCRJ:0078, BioGRID_ORCS_Cell_line:860, BioSample:SAMN03472017, BioSample:SAMN03472041, BioSample:SAMN03472757, BioSample:SAMN05292468, BioSample:SAMN10988253, cancercelllines:CVCL_0105, CCRID:1101HUM-PUMC000006, CCRID:3101HUMSCSP5024, CCRID:3101HUMTCHu222, Cell_Model_Passport:SIDM00120, ChEMBL-Cells:CHEMBL3308034, ChEMBL-Targets:CHEMBL613508, CLS:300168, Cosmic:688116, Cosmic:699306, Cosmic:704850, Cosmic:721367, Cosmic:721558, Cosmic:755299, Cosmic:759893, Cosmic:801349, Cosmic:809223, Cosmic:809224, Cosmic:850415, Cosmic:850824, Cosmic:869156, Cosmic:875891, Cosmic:876395, Cosmic:897454, Cosmic:905935, Cosmic:911998, Cosmic:918501, Cosmic:921050, Cosmic:922550, Cosmic:923401, Cosmic:923956, Cosmic:943177, Cosmic:948075, Cosmic:949247, Cosmic:974300, Cosmic:1028649, Cosmic:1028700, Cosmic:1057758, Cosmic:1070887, Cosmic:1071478, Cosmic:1071905, Cosmic:1075274, Cosmic:1092597, Cosmic:1172627, Cosmic:1175887, Cosmic:1176617, Cosmic:1212490, Cosmic:1218869, Cosmic:1305381, Cosmic:1312368, Cosmic:1330912, Cosmic:1436047, Cosmic:1481419, Cosmic:1542078, Cosmic:1689715, Cosmic:1712065, Cosmic:1995389, Cosmic:1998439, Cosmic:2580127, Cosmic:2585152, Cosmic:2585229, Cosmic:2592487, Cosmic:2651768, Cosmic:2669167, Cosmic:2674179, Cosmic:2816220, Cosmic-CLP:905935, DepMap:ACH-000979, DSMZ:ACC-261, DSMZCellDive:ACC-261, EGA:EGAS00001000610, EGA:EGAS00001000978, ENCODE:ENCBS077VSE, ENCODE:ENCBS721QHV, FANTOM5_SSTAR:10490-107B4, GDSC:905935, GEO:GSM2120, GEO:GSM50224, GEO:GSM50288, GEO:GSM91924, GEO:GSM142455, GEO:GSM142456, GEO:GSM482671, GEO:GSM525794, GEO:GSM648818, GEO:GSM648819, GEO:GSM743479, GEO:GSM750774, GEO:GSM750834, GEO:GSM784791, GEO:GSM799369, GEO:GSM799379, GEO:GSM799432, GEO:GSM799442, GEO:GSM843494, GEO:GSM886988, GEO:GSM888057, GEO:GSM1153440, GEO:GSM1153441, GEO:GSM1181273, GEO:GSM1181302, GEO:GSM1181306, GEO:GSM1181328, GEO:GSM1374469, GEO:GSM1374470, GEO:GSM1669745, GEO:GSM2124639, IARC_TP53:751, ICLC:HTL99013, IZSLER:BS TCL 141, KCB:KCB 200701YJ, KCLB:30081, LiGeA:CCLE_356, LINCS_LDP:LCL-1146, Lonza:761, NCBI_Iran:C428, NCI-DTP:DU-145, PharmacoDB:DU145_309_2019, PRIDE:PXD003105, PRIDE:PXD003539, PRIDE:PXD005942, PRIDE:PXD005946, PRIDE:PXD030304, Progenetix:CVCL_0105, PubChem_Cell_line:CVCL_0105, RCB:RCB2143, SKY/M-FISH/CGH:2792, TKG:TKG 0604, TOKU-E:1103, Wikidata:Q5206280 |
|
|
CVCL_0105 |
2026-09-12 05:30:23 |
4400 |
DU4475
Resource Report
Resource Website
10+ mentions
Discontinued
|
RRID:CVCL_1183
|
Homo sapiens (Human)
|
Breast carcinoma
|
Caution: Reported by some sites and publications to originate from a 62 year old woman, but the cell line was established when she was 70 year old., Population: Caucasian., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: JWGray breast cancer cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: BRAF genetic alteration cell panel (ATCC TCP-1032)., Group: Triple negative breast cancer (TNBC) cell line.
|
PMID:221108 PMID:10862037 PMID:11343771 PMID:11414198 PMID:12068308 PMID:15677628 PMID:16397213 PMID:16541312 PMID:18397470 PMID:19593635 PMID:20164919 PMID:20215515 PMID:22460905 PMID:23601657 PMID:24094812 PMID:25485619 PMID:25877200 PMID:25892236 PMID:25984343 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
Du4475, DU-4475, Du-4475, DU 4475, Du 4475, Duke University 4475 |
|
|
CLO:CLO_0002842, EFO:EFO_0002168, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-7921, ATCC:HTB-123, BioGRID_ORCS_Cell_line:684, BioSample:SAMN03471772, BioSample:SAMN03473595, BioSample:SAMN05292453, BioSample:SAMN10987660, cancercelllines:CVCL_1183, CCRID:1101HUM-PUMC000342, Cell_Model_Passport:SIDM01001, ChEMBL-Cells:CHEMBL3308261, ChEMBL-Targets:CHEMBL2366246, CLS:300371, Cosmic:685863, Cosmic:871141, Cosmic:904355, Cosmic:906844, Cosmic:921975, Cosmic:934523, Cosmic:997915, Cosmic:1046952, Cosmic:1047716, Cosmic:1091340, Cosmic:1152520, Cosmic:1287936, Cosmic:1289387, Cosmic:1609476, Cosmic:2164988, Cosmic-CLP:906844, DepMap:ACH-000258, DSMZ:ACC-427, DSMZCellDive:ACC-427, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:906844, GEO:GSM217568, GEO:GSM274659, GEO:GSM344345, GEO:GSM344395, GEO:GSM421865, GEO:GSM783961, GEO:GSM886989, GEO:GSM888058, GEO:GSM1053707, GEO:GSM1669746, IARC_TP53:21043, IGRhCellID:DU4475, LiGeA:CCLE_395, LINCS_HMS:50577, LINCS_LDP:LCL-1323, PharmacoDB:DU4475_310_2019, PRIDE:PXD008222, PRIDE:PXD030304, Progenetix:CVCL_1183, PubChem_Cell_line:CVCL_1183, SLKBase:3415, Wikidata:Q54831578 |
|
|
CVCL_1183 |
2026-09-12 05:30:23 |
19 |
EB1
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_2027
|
Homo sapiens (Human)
|
EBV-related Burkitt lymphoma
|
Population: African; Ugandan., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2998993 PMID:3518877 PMID:4894370 PMID:5884338 PMID:6018567 PMID:7316467 PMID:8515068 PMID:8558920 PMID:12145705 PMID:14090852 PMID:14293790 PMID:14293791 PMID:20215515 PMID:20454443 PMID:22460905 PMID:24590883 PMID:25485619 PMID:25877200 PMID:26589293 PMID:28196595 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700
|
Cancer cell line
|
Female |
EB-1, Epstein-Barr-1 |
|
|
BTO:BTO_0003000, CLO:CLO_0002869, CLO:CLO_0002870, EFO:EFO_0002172, CLDB:cl1127, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:HTB-60, BioSample:SAMN03472402, BioSample:SAMN03473402, BioSample:SAMN10987945, cancercelllines:CVCL_2027, Cell_Model_Passport:SIDM00862, CLS:300403, Cosmic:1086328, Cosmic:1818341, DepMap:ACH-000877, DSMZ:ACC-80, DSMZCellDive:ACC-80, EGA:EGAS00001000610, GEO:GSM827341, GEO:GSM886991, GEO:GSM888060, IARC_TP53:21315, IGRhCellID:EB1, LiGeA:CCLE_384, LINCS_LDP:LCL-2030, PharmacoDB:EB1_313_2019, Progenetix:CVCL_2027, Wikidata:Q54831741 |
|
|
CVCL_2027 |
2026-09-12 05:30:27 |
5 |
EB3 [Human Burkitt lymphoma]
Resource Report
Resource Website
1+ mentions
Partially Contaminated Discontinued
|
RRID:CVCL_1185
|
Homo sapiens (Human)
|
EBV-related Burkitt lymphoma
|
Population: African; Ugandan., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Partially contaminated. Some stocks (such as IFO50028) were contaminated by Daudi..
|
PMID:2052620 PMID:2985879 PMID:2998993 PMID:3159941 PMID:3518877 PMID:3874327 PMID:4169243 PMID:4342611 PMID:4736620 PMID:4894370 PMID:5884338 PMID:6018567 PMID:6286763 PMID:7316467 PMID:8515068 PMID:20164919 PMID:20215515 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:30894373 PMID:35839778
|
Cancer cell line
|
Male |
EB-3, Epstein-Barr-3, GM04679 |
|
|
CLO:CLO_0002874, CLO:CLO_0019013, EFO:EFO_0002174, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CCL-85, BioSample:SAMN03473119, cancercelllines:CVCL_1185, CCRID:1101HUM-PUMC000343, Cell_Model_Passport:SIDM00793, CGH-DB:9198-4, ChEMBL-Cells:CHEMBL3308824, ChEMBL-Targets:CHEMBL2366369, CLS:300373, Coriell:GM04679, Cosmic:687840, Cosmic:906847, Cosmic:1818343, Cosmic-CLP:906847, DepMap:ACH-002236, ECACC:90121003, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:906847, GEO:GSM1669748, IARC_TP53:155, IARC_TP53:21145, IGRhCellID:EB3, JCRB:IFO50028, LINCS_LDP:LCL-2032, PharmacoDB:EB3_312_2019, PRIDE:PXD030304, Progenetix:CVCL_1185, PubChem_Cell_line:CVCL_1185, Wikidata:Q54831748 |
|
|
CVCL_1185 |
2026-09-12 05:30:27 |
1 |
EC-GI-10
Resource Report
Resource Website
|
RRID:CVCL_1187
|
Homo sapiens (Human)
|
Esophageal squamous cell carcinoma
|
Characteristics: Established from a mouse xenograft., Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2824416 PMID:3261732 PMID:11416159 PMID:20164919 PMID:22460905 PMID:26589293 PMID:27397505 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
ECGI10, EC-GI |
|
|
CLO:CLO_0051378, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:862, BioSample:SAMN03472227, BioSample:SAMN10987728, cancercelllines:CVCL_1187, Cell_Model_Passport:SIDM00278, ChEMBL-Cells:CHEMBL3308289, ChEMBL-Targets:CHEMBL2366240, Cosmic:753555, Cosmic-CLP:753555, DepMap:ACH-000305, EGA:EGAS00001000978, FANTOM5_SSTAR:10463-106H4, GDSC:753555, GEO:GSM886996, GEO:GSM888065, GEO:GSM1669753, IARC_TP53:21317, LiGeA:CCLE_378, LINCS_LDP:LCL-1151, PharmacoDB:ECGI10_316_2019, PRIDE:PXD030304, Progenetix:CVCL_1187, PubChem_Cell_line:CVCL_1187, RCB:RCB0774, Wikidata:Q54831834 |
|
|
CVCL_1187 |
2026-09-12 05:30:29 |
0 |
ECC10
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1188
|
Homo sapiens (Human)
|
Gastric small cell carcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8392984 PMID:20164919 PMID:22460905 PMID:26589293 PMID:27397505 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
ECC-10, ECC 10 |
|
|
CLO:CLO_0050796, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03472196, BioSample:SAMN10987724, cancercelllines:CVCL_1188, Cell_Model_Passport:SIDM00280, ChEMBL-Cells:CHEMBL3308191, ChEMBL-Targets:CHEMBL2366117, Cosmic:848376, Cosmic:906848, Cosmic:1187269, Cosmic-CLP:906848, DepMap:ACH-000560, EGA:EGAS00001000978, FANTOM5_SSTAR:10610-108F7, GDSC:906848, GEO:GSM886994, GEO:GSM888063, GEO:GSM1669750, IARC_TP53:21318, LiGeA:CCLE_472, LINCS_LDP:LCL-1897, PharmacoDB:ECC10_317_2019, PRIDE:PXD030304, Progenetix:CVCL_1188, PubChem_Cell_line:CVCL_1188, RCB:RCB0983, Wikidata:Q54831922 |
|
|
CVCL_1188 |
2026-09-12 05:30:30 |
2 |
HEC-50B
Resource Report
Resource Website
1+ mentions
Discontinued
|
RRID:CVCL_2929
|
Homo sapiens (Human)
|
Type II endometrial adenocarcinoma
|
Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2064198 PMID:10381137 PMID:12893190 PMID:15053063 PMID:22460905 PMID:22710073 PMID:25877200 PMID:26589293 PMID:28196595 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Female |
HEC50B, HEC-50 clone B, HEC-50, HEC50, Hec50 |
|
|
ArrayExpress:E-MTAB-2770, BioGRID_ORCS_Cell_line:718, BioSample:SAMN03470885, BioSample:SAMN10987854, cancercelllines:CVCL_2929, Cell_Model_Passport:SIDM01614, Cosmic:1223491, Cosmic:1576459, Cosmic:1696760, Cosmic:2030471, DepMap:ACH-000831, GEO:GSM887073, GEO:GSM888143, JCRB:JCRB1145, JCRB:NIHS0391, LiGeA:CCLE_584, PharmacoDB:HEC50B_529_2019, Progenetix:CVCL_2929, Wikidata:Q54882264 |
|
|
CVCL_2929 |
2026-09-12 05:40:03 |
3 |
HEC-151
Resource Report
Resource Website
1+ mentions
Discontinued
|
RRID:CVCL_2925
|
Homo sapiens (Human)
|
Endometrial adenocarcinoma
|
Population: Japanese., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2064198 PMID:15053063 PMID:22460905 PMID:25877200 PMID:26589293 PMID:30894373 PMID:31068700
|
Cancer cell line
|
Female |
HEC151 |
|
|
ArrayExpress:E-MTAB-2770, BioSample:SAMN03470938, BioSample:SAMN10987651, cancercelllines:CVCL_2925, Cell_Model_Passport:SIDM01609, Cosmic:1696754, Cosmic:2030468, DepMap:ACH-000972, GEO:GSM887068, GEO:GSM888138, IARC_TP53:21066, IARC_TP53:30206, JCRB:JCRB1122, JCRB:NIHS0396, LiGeA:CCLE_926, PharmacoDB:HEC151_526_2019, Progenetix:CVCL_2925, Wikidata:Q54882256 |
|
|
CVCL_2925 |
2026-09-12 05:40:03 |
2 |
HEC-251
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_2927
|
Homo sapiens (Human)
|
Endometrial carcinoma
|
Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:15053063 PMID:15171304 PMID:22460905 PMID:25877200 PMID:26589293 PMID:28196595 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Female |
HEC251 |
|
|
ArrayExpress:E-MTAB-2770, BioGRID_ORCS_Cell_line:719, BioSample:SAMD00048820, BioSample:SAMN03470931, BioSample:SAMN10987959, cancercelllines:CVCL_2927, Cell_Model_Passport:SIDM01611, Cosmic:2030469, DepMap:ACH-000996, GEO:GSM887071, GEO:GSM888141, IARC_TP53:20593, JCRB:JCRB1141, LiGeA:CCLE_436, PharmacoDB:HEC251_527_2019, Progenetix:CVCL_2927, Wikidata:Q54882261 |
|
|
CVCL_2927 |
2026-09-12 05:40:03 |
3 |
HEC-59
Resource Report
Resource Website
1+ mentions
Discontinued
|
RRID:CVCL_2930
|
Homo sapiens (Human)
|
Endometrial adenocarcinoma
|
Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2064198 PMID:9000572 PMID:10381137 PMID:12227503 PMID:15053063 PMID:20944090 PMID:22460905 PMID:25877200 PMID:26589293 PMID:28196595 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Female |
HEC59, Hec59 |
|
|
AddexBio:C0026001/42, ArrayExpress:E-MTAB-2770, BioGRID_ORCS_Cell_line:717, BioSample:SAMN03470882, BioSample:SAMN03472458, BioSample:SAMN10988108, cancercelllines:CVCL_2930, Cell_Model_Passport:SIDM01617, Cosmic:1070806, Cosmic:1223492, Cosmic:1576460, Cosmic:1622901, Cosmic:1696750, Cosmic:2030472, DepMap:ACH-000994, GEO:GSM887074, GEO:GSM888144, IARC_TP53:20591, JCRB:JCRB1120, JCRB:NIHS0392, LiGeA:CCLE_600, PharmacoDB:HEC59_530_2019, Progenetix:CVCL_2930, Wikidata:Q54882265 |
|
|
CVCL_2930 |
2026-09-12 05:40:03 |
1 |
HEC-265
Resource Report
Resource Website
1+ mentions
Discontinued
|
RRID:CVCL_2928
|
Homo sapiens (Human)
|
Endometrial adenocarcinoma
|
Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:15053063 PMID:15171304 PMID:22460905 PMID:25877200 PMID:26589293 PMID:28196595 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Female |
HEC265 |
|
|
ArrayExpress:E-MTAB-2770, BioSample:SAMD00048821, BioSample:SAMN03470883, BioSample:SAMN10987845, cancercelllines:CVCL_2928, Cell_Model_Passport:SIDM01612, Cosmic:2030470, DepMap:ACH-000946, GEO:GSM887072, GEO:GSM888142, IARC_TP53:21067, JCRB:JCRB1142, JCRB:NIHS0400, LiGeA:CCLE_015, PharmacoDB:HEC265_528_2019, Progenetix:CVCL_2928, Wikidata:Q54882262 |
|
|
CVCL_2928 |
2026-09-12 05:40:03 |
4 |
HEC-1-B
Resource Report
Resource Website
100+ mentions
Discontinued
|
RRID:CVCL_0294
|
Homo sapiens (Human)
|
Type II endometrial adenocarcinoma
|
Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:327080 PMID:833871 PMID:3518877 PMID:4678779 PMID:6163305 PMID:6174649 PMID:6220172 PMID:12227503 PMID:20215515 PMID:20218740 PMID:20944090 PMID:22460905 PMID:22710073 PMID:25877200 PMID:28196595 PMID:30894373 PMID:31068700
|
Cancer cell line
|
Female |
Hec-1-B, HEC-1B, Hec-1b, HEC1-B, HEC1B, Hec1B |
|
|
BTO:BTO_0003038, CLO:CLO_0003675, EFO:EFO_0002192, MCCL:MCC:0000184, CLDB:cl1582, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2770, ATCC:HTB-113, BioGRID_ORCS_Cell_line:420, BioSample:SAMN03471094, BioSample:SAMN03472427, BioSample:SAMN03473077, BioSample:SAMN10987737, cancercelllines:CVCL_0294, CCRID:1101HUM-PUMC000105, CCRID:3101HUMTCHu115, CCRID:4201HUM-CCTCC00129, CCTCC:GDC0129, Cell_Model_Passport:SIDM01241, ChEMBL-Cells:CHEMBL3308662, ChEMBL-Targets:CHEMBL614817, CLS:305095, Cosmic:687552, Cosmic:809131, Cosmic:846178, Cosmic:980635, Cosmic:1070807, Cosmic:1177621, Cosmic:1223486, Cosmic:1241345, Cosmic:1576458, Cosmic:1696757, Cosmic:2030465, DepMap:ACH-000941, GEO:GSM844557, GEO:GSM887070, GEO:GSM888140, IARC_TP53:1111, IGRhCellID:HEC1B, JCRB:JCRB1193, JCRB:NIHS0480, KCB:KCB 200551YJ, LiGeA:CCLE_480, PharmacoDB:HEC1B_532_2019, Progenetix:CVCL_0294, PubChem_Cell_line:CVCL_0294, Ubigene:YC-C108, Wikidata:Q54882253 |
cvcl_0293 |
|
CVCL_0294 |
2026-09-12 05:40:03 |
228 |
HEC-6
Resource Report
Resource Website
1+ mentions
Discontinued
|
RRID:CVCL_2931
|
Homo sapiens (Human)
|
Endometrial endometrioid adenocarcinoma, variant with squamous differentiation
|
Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:862644 PMID:2064198 PMID:10381137 PMID:15053063 PMID:22460905 PMID:25877200 PMID:26589293 PMID:28196595 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Female |
HEC6 |
|
|
ArrayExpress:E-MTAB-2770, BioGRID_ORCS_Cell_line:716, BioSample:SAMN03470939, BioSample:SAMN03472457, BioSample:SAMN10987852, cancercelllines:CVCL_2931, Cell_Model_Passport:SIDM01619, Cosmic:1223490, Cosmic:1696749, Cosmic:2030473, DepMap:ACH-000984, GEO:GSM887075, GEO:GSM888145, IARC_TP53:21068, IARC_TP53:30207, JCRB:JCRB1118, JCRB:NIHS0390, LiGeA:CCLE_478, PharmacoDB:HEC6_531_2019, Progenetix:CVCL_2931, Wikidata:Q54882266 |
|
|
CVCL_2931 |
2026-09-12 05:40:03 |
3 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
BCRJ Cat# 0100, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569 PMID:1246620 PMID:1522048 PMID:2983228 PMID:2990217 PMID:3028716 PMID:3180844 PMID:3371749 PMID:3518877 PMID:4942173 PMID:5668122 PMID:6256643 PMID:6358339 PMID:6401685 PMID:6825208 PMID:6935474 PMID:8380785 PMID:9892199 PMID:10423141 PMID:11416159 PMID:11668190 PMID:12001993 PMID:12661003 PMID:12793746 PMID:13052828 PMID:13207312 PMID:13261081 PMID:14031339 PMID:14185313 PMID:15302935 PMID:15531914 PMID:15901131 PMID:16589695 PMID:16957166 PMID:17311676 PMID:19450234 PMID:19722756 PMID:19941903 PMID:21269460 PMID:21937730 PMID:22068331 PMID:22278370 PMID:22412903 PMID:23205564 PMID:23336012 PMID:23925224 PMID:23925245 PMID:24134916 PMID:24618588 PMID:24696503 PMID:24908793 PMID:25485619 PMID:25807930 PMID:25877200 PMID:25894527 PMID:25960936 PMID:26554430 PMID:26589293 PMID:27397505 PMID:28078501 PMID:28196595 PMID:28261610 PMID:28601559 PMID:29156801 PMID:30175587 PMID:30778230 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31433507 PMID:31790455 PMID:33389257 PMID:35198691 PMID:35839778 PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
BCRJ |
0100 |
BTO:BTO_0000567, CLO:CLO_0003684, CLO:CLO_0050910, EFO:EFO_0001185, MCCL:MCC:0000219, CLDB:cl1594, CLDB:cl1595, CLDB:cl1596, CLDB:cl1597, CLDB:cl1599, CLDB:cl1600, CLDB:cl1601, CLDB:cl1603, Abcam:ab255448, Abcam:ab255928, Abcam:ab260075, Abcam:ab271142, Abcam:ab275466, AddexBio:C0008001/44, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CCL-2, ATCC:CRL-7923, ATCC:CRM-CCL-2, BCRC:60005, BCRJ:0100, BEI_Resources:ARP-153, BioGRID_ORCS_Cell_line:95, BioSample:SAMN03471148, BioSample:SAMN03472333, BioSample:SAMN10989629, cancercelllines:CVCL_0030, CCLV:CCLV-RIE 0082, CCRID:1101HUM-PUMC000011, CCRID:1101HUM-PUMC000332, CCRID:1102HUM-NIFDC00057, CCRID:3101HUMSCSP504, CCRID:3101HUMTCHu187, CCRID:4201HUM-CCTCC00009, CCRID:5301HUM-KCB90024YJ, CCTCC:GDC0009, Cell_Model_Passport:SIDM00846, ChEMBL-Cells:CHEMBL3308376, ChEMBL-Targets:CHEMBL399, CLS:300194, Cosmic:760219, Cosmic:760490, Cosmic:801357, Cosmic:809231, Cosmic:877477, Cosmic:911999, Cosmic:925354, Cosmic:928907, Cosmic:944113, Cosmic:1019309, Cosmic:1057766, Cosmic:1071911, Cosmic:1131525, Cosmic:1193029, Cosmic:1201779, Cosmic:1324208, Cosmic:1336880, Cosmic:1571796, Cosmic:2301539, Cosmic:2660190, Cosmic:2750874, Cosmic:2791019, Cosmic:2816214, Cosmic-CLP:1298134, dbGAP:phs000640.v4.p1, DepMap:ACH-001086, DSMZ:ACC-57, DSMZCellDive:ACC-57, ECACC:93021013, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:phs000640, FCS-free:44-2-47-1-8-9, GDSC:1298134, GEO:GSM113863, GEO:GSM226739, GEO:GSM226875, GEO:GSM253298, GEO:GSM436128, GEO:GSM436129, GEO:GSM501788, GEO:GSM722574, GEO:GSM722575, GEO:GSM723055, GEO:GSM723056, GEO:GSM1088663, GEO:GSM1088664, GEO:GSM1088665, GEO:GSM1088666, GEO:GSM1374528, GEO:GSM1669875, GEO:GSM1881473, GEO:GSM1881474, GEO:GSM1881475, GEO:GSM7701367, GEO:GSM7701368, Hysigen:TCH-C193, ICLC:HTL95023, IGRhCellID:HeLA, IZSLER:BS TCL 20, JCRB:JCRB9004, KCB:KCB 86019YJ, KCB:KCB 90024YJ, KCLB:10002, LINCS_HMS:50061, LINCS_LDP:LCL-1512, Lonza:51, MeSH:D006367, NCBI_Iran:C115, PharmacoDB:HeLa_536_2019, PRIDE:PRD000007, PRIDE:PRD000032, PRIDE:PRD000123, PRIDE:PRD000124, PRIDE:PRD000345, PRIDE:PRD000376, PRIDE:PRD000525, PRIDE:PRD000526, PRIDE:PRD000527, PRIDE:PXD000013, PRIDE:PXD000243, PRIDE:PXD000252, PRIDE:PXD000279, PRIDE:PXD000396, PRIDE:PXD000474, PRIDE:PXD000589, PRIDE:PXD000661, PRIDE:PXD000680, PRIDE:PXD000759, PRIDE:PXD000883, PRIDE:PXD000895, PRIDE:PXD000900, PRIDE:PXD000953, PRIDE:PXD000954, PRIDE:PXD000999, PRIDE:PXD001047, PRIDE:PXD001118, PRIDE:PXD001154, PRIDE:PXD001175, PRIDE:PXD001249, PRIDE:PXD001258, PRIDE:PXD001259, PRIDE:PXD001278, PRIDE:PXD001305, PRIDE:PXD001374, PRIDE:PXD001381, PRIDE:PXD001396, PRIDE:PXD001441, PRIDE:PXD001541, PRIDE:PXD001548, PRIDE:PXD001574, PRIDE:PXD001660, PRIDE:PXD001781, PRIDE:PXD001798, PRIDE:PXD001805, PRIDE:PXD001806, PRIDE:PXD001810, PRIDE:PXD001863, PRIDE:PXD001907, PRIDE:PXD002001, PRIDE:PXD002039, PRIDE:PXD002066, PRIDE:PXD002252, PRIDE:PXD002277, PRIDE:PXD002378, PRIDE:PXD002383, PRIDE:PXD002395, PRIDE:PXD002572, PRIDE:PXD002591, PRIDE:PXD002704, PRIDE:PXD002844, PRIDE:PXD002880, PRIDE:PXD003186, PRIDE:PXD003209, PRIDE:PXD003258, PRIDE:PXD003370, PRIDE:PXD003503, PRIDE:PXD003530, PRIDE:PXD003560, PRIDE:PXD003792, PRIDE:PXD003813, PRIDE:PXD003909, PRIDE:PXD003913, PRIDE:PXD003917, PRIDE:PXD003924, PRIDE:PXD004182, PRIDE:PXD004271, PRIDE:PXD004273, PRIDE:PXD004452, PRIDE:PXD004613, PRIDE:PXD004736, PRIDE:PXD004900, PRIDE:PXD004914, PRIDE:PXD004933, PRIDE:PXD004934, PRIDE:PXD004940, PRIDE:PXD004995, PRIDE:PXD005018, PRIDE:PXD005107, PRIDE:PXD005181, PRIDE:PXD005346, PRIDE:PXD005349, PRIDE:PXD005366, PRIDE:PXD005466, PRIDE:PXD005509, PRIDE:PXD005572, PRIDE:PXD005712, PRIDE:PXD005955, PRIDE:PXD006112, PRIDE:PXD006293, PRIDE:PXD012045, PRIDE:PXD012188, PRIDE:PXD013064, PRIDE:PXD023271, PRIDE:PXD023835, PRIDE:PXD027504, PRIDE:PXD029773, PRIDE:PXD030304, Progenetix:CVCL_0030, PubChem_Cell_line:CVCL_0030, RCB:RCB0007, RCB:RCB3680, SKY/M-FISH/CGH:5351, TKG:TKG 0331, TOKU-E:1434, Ubigene:YC-A012, Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-09-12 05:40:14 |
39236 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
ATCC Cat# CRL-7923, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569 PMID:1246620 PMID:1522048 PMID:2983228 PMID:2990217 PMID:3028716 PMID:3180844 PMID:3371749 PMID:3518877 PMID:4942173 PMID:5668122 PMID:6256643 PMID:6358339 PMID:6401685 PMID:6825208 PMID:6935474 PMID:8380785 PMID:9892199 PMID:10423141 PMID:11416159 PMID:11668190 PMID:12001993 PMID:12661003 PMID:12793746 PMID:13052828 PMID:13207312 PMID:13261081 PMID:14031339 PMID:14185313 PMID:15302935 PMID:15531914 PMID:15901131 PMID:16589695 PMID:16957166 PMID:17311676 PMID:19450234 PMID:19722756 PMID:19941903 PMID:21269460 PMID:21937730 PMID:22068331 PMID:22278370 PMID:22412903 PMID:23205564 PMID:23336012 PMID:23925224 PMID:23925245 PMID:24134916 PMID:24618588 PMID:24696503 PMID:24908793 PMID:25485619 PMID:25807930 PMID:25877200 PMID:25894527 PMID:25960936 PMID:26554430 PMID:26589293 PMID:27397505 PMID:28078501 PMID:28196595 PMID:28261610 PMID:28601559 PMID:29156801 PMID:30175587 PMID:30778230 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31433507 PMID:31790455 PMID:33389257 PMID:35198691 PMID:35839778 PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
ATCC |
CRL-7923 |
BTO:BTO_0000567, CLO:CLO_0003684, CLO:CLO_0050910, EFO:EFO_0001185, MCCL:MCC:0000219, CLDB:cl1594, CLDB:cl1595, CLDB:cl1596, CLDB:cl1597, CLDB:cl1599, CLDB:cl1600, CLDB:cl1601, CLDB:cl1603, Abcam:ab255448, Abcam:ab255928, Abcam:ab260075, Abcam:ab271142, Abcam:ab275466, AddexBio:C0008001/44, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CCL-2, ATCC:CRL-7923, ATCC:CRM-CCL-2, BCRC:60005, BCRJ:0100, BEI_Resources:ARP-153, BioGRID_ORCS_Cell_line:95, BioSample:SAMN03471148, BioSample:SAMN03472333, BioSample:SAMN10989629, cancercelllines:CVCL_0030, CCLV:CCLV-RIE 0082, CCRID:1101HUM-PUMC000011, CCRID:1101HUM-PUMC000332, CCRID:1102HUM-NIFDC00057, CCRID:3101HUMSCSP504, CCRID:3101HUMTCHu187, CCRID:4201HUM-CCTCC00009, CCRID:5301HUM-KCB90024YJ, CCTCC:GDC0009, Cell_Model_Passport:SIDM00846, ChEMBL-Cells:CHEMBL3308376, ChEMBL-Targets:CHEMBL399, CLS:300194, Cosmic:760219, Cosmic:760490, Cosmic:801357, Cosmic:809231, Cosmic:877477, Cosmic:911999, Cosmic:925354, Cosmic:928907, Cosmic:944113, Cosmic:1019309, Cosmic:1057766, Cosmic:1071911, Cosmic:1131525, Cosmic:1193029, Cosmic:1201779, Cosmic:1324208, Cosmic:1336880, Cosmic:1571796, Cosmic:2301539, Cosmic:2660190, Cosmic:2750874, Cosmic:2791019, Cosmic:2816214, Cosmic-CLP:1298134, dbGAP:phs000640.v4.p1, DepMap:ACH-001086, DSMZ:ACC-57, DSMZCellDive:ACC-57, ECACC:93021013, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:phs000640, FCS-free:44-2-47-1-8-9, GDSC:1298134, GEO:GSM113863, GEO:GSM226739, GEO:GSM226875, GEO:GSM253298, GEO:GSM436128, GEO:GSM436129, GEO:GSM501788, GEO:GSM722574, GEO:GSM722575, GEO:GSM723055, GEO:GSM723056, GEO:GSM1088663, GEO:GSM1088664, GEO:GSM1088665, GEO:GSM1088666, GEO:GSM1374528, GEO:GSM1669875, GEO:GSM1881473, GEO:GSM1881474, GEO:GSM1881475, GEO:GSM7701367, GEO:GSM7701368, Hysigen:TCH-C193, ICLC:HTL95023, IGRhCellID:HeLA, IZSLER:BS TCL 20, JCRB:JCRB9004, KCB:KCB 86019YJ, KCB:KCB 90024YJ, KCLB:10002, LINCS_HMS:50061, LINCS_LDP:LCL-1512, Lonza:51, MeSH:D006367, NCBI_Iran:C115, PharmacoDB:HeLa_536_2019, PRIDE:PRD000007, PRIDE:PRD000032, PRIDE:PRD000123, PRIDE:PRD000124, PRIDE:PRD000345, PRIDE:PRD000376, PRIDE:PRD000525, PRIDE:PRD000526, PRIDE:PRD000527, PRIDE:PXD000013, PRIDE:PXD000243, PRIDE:PXD000252, PRIDE:PXD000279, PRIDE:PXD000396, PRIDE:PXD000474, PRIDE:PXD000589, PRIDE:PXD000661, PRIDE:PXD000680, PRIDE:PXD000759, PRIDE:PXD000883, PRIDE:PXD000895, PRIDE:PXD000900, PRIDE:PXD000953, PRIDE:PXD000954, PRIDE:PXD000999, PRIDE:PXD001047, PRIDE:PXD001118, PRIDE:PXD001154, PRIDE:PXD001175, PRIDE:PXD001249, PRIDE:PXD001258, PRIDE:PXD001259, PRIDE:PXD001278, PRIDE:PXD001305, PRIDE:PXD001374, PRIDE:PXD001381, PRIDE:PXD001396, PRIDE:PXD001441, PRIDE:PXD001541, PRIDE:PXD001548, PRIDE:PXD001574, PRIDE:PXD001660, PRIDE:PXD001781, PRIDE:PXD001798, PRIDE:PXD001805, PRIDE:PXD001806, PRIDE:PXD001810, PRIDE:PXD001863, PRIDE:PXD001907, PRIDE:PXD002001, PRIDE:PXD002039, PRIDE:PXD002066, PRIDE:PXD002252, PRIDE:PXD002277, PRIDE:PXD002378, PRIDE:PXD002383, PRIDE:PXD002395, PRIDE:PXD002572, PRIDE:PXD002591, PRIDE:PXD002704, PRIDE:PXD002844, PRIDE:PXD002880, PRIDE:PXD003186, PRIDE:PXD003209, PRIDE:PXD003258, PRIDE:PXD003370, PRIDE:PXD003503, PRIDE:PXD003530, PRIDE:PXD003560, PRIDE:PXD003792, PRIDE:PXD003813, PRIDE:PXD003909, PRIDE:PXD003913, PRIDE:PXD003917, PRIDE:PXD003924, PRIDE:PXD004182, PRIDE:PXD004271, PRIDE:PXD004273, PRIDE:PXD004452, PRIDE:PXD004613, PRIDE:PXD004736, PRIDE:PXD004900, PRIDE:PXD004914, PRIDE:PXD004933, PRIDE:PXD004934, PRIDE:PXD004940, PRIDE:PXD004995, PRIDE:PXD005018, PRIDE:PXD005107, PRIDE:PXD005181, PRIDE:PXD005346, PRIDE:PXD005349, PRIDE:PXD005366, PRIDE:PXD005466, PRIDE:PXD005509, PRIDE:PXD005572, PRIDE:PXD005712, PRIDE:PXD005955, PRIDE:PXD006112, PRIDE:PXD006293, PRIDE:PXD012045, PRIDE:PXD012188, PRIDE:PXD013064, PRIDE:PXD023271, PRIDE:PXD023835, PRIDE:PXD027504, PRIDE:PXD029773, PRIDE:PXD030304, Progenetix:CVCL_0030, PubChem_Cell_line:CVCL_0030, RCB:RCB0007, RCB:RCB3680, SKY/M-FISH/CGH:5351, TKG:TKG 0331, TOKU-E:1434, Ubigene:YC-A012, Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-09-12 05:40:14 |
39236 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
RCB Cat# RCB3680, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569 PMID:1246620 PMID:1522048 PMID:2983228 PMID:2990217 PMID:3028716 PMID:3180844 PMID:3371749 PMID:3518877 PMID:4942173 PMID:5668122 PMID:6256643 PMID:6358339 PMID:6401685 PMID:6825208 PMID:6935474 PMID:8380785 PMID:9892199 PMID:10423141 PMID:11416159 PMID:11668190 PMID:12001993 PMID:12661003 PMID:12793746 PMID:13052828 PMID:13207312 PMID:13261081 PMID:14031339 PMID:14185313 PMID:15302935 PMID:15531914 PMID:15901131 PMID:16589695 PMID:16957166 PMID:17311676 PMID:19450234 PMID:19722756 PMID:19941903 PMID:21269460 PMID:21937730 PMID:22068331 PMID:22278370 PMID:22412903 PMID:23205564 PMID:23336012 PMID:23925224 PMID:23925245 PMID:24134916 PMID:24618588 PMID:24696503 PMID:24908793 PMID:25485619 PMID:25807930 PMID:25877200 PMID:25894527 PMID:25960936 PMID:26554430 PMID:26589293 PMID:27397505 PMID:28078501 PMID:28196595 PMID:28261610 PMID:28601559 PMID:29156801 PMID:30175587 PMID:30778230 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31433507 PMID:31790455 PMID:33389257 PMID:35198691 PMID:35839778 PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
RCB |
RCB3680 |
BTO:BTO_0000567, CLO:CLO_0003684, CLO:CLO_0050910, EFO:EFO_0001185, MCCL:MCC:0000219, CLDB:cl1594, CLDB:cl1595, CLDB:cl1596, CLDB:cl1597, CLDB:cl1599, CLDB:cl1600, CLDB:cl1601, CLDB:cl1603, Abcam:ab255448, Abcam:ab255928, Abcam:ab260075, Abcam:ab271142, Abcam:ab275466, AddexBio:C0008001/44, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CCL-2, ATCC:CRL-7923, ATCC:CRM-CCL-2, BCRC:60005, BCRJ:0100, BEI_Resources:ARP-153, BioGRID_ORCS_Cell_line:95, BioSample:SAMN03471148, BioSample:SAMN03472333, BioSample:SAMN10989629, cancercelllines:CVCL_0030, CCLV:CCLV-RIE 0082, CCRID:1101HUM-PUMC000011, CCRID:1101HUM-PUMC000332, CCRID:1102HUM-NIFDC00057, CCRID:3101HUMSCSP504, CCRID:3101HUMTCHu187, CCRID:4201HUM-CCTCC00009, CCRID:5301HUM-KCB90024YJ, CCTCC:GDC0009, Cell_Model_Passport:SIDM00846, ChEMBL-Cells:CHEMBL3308376, ChEMBL-Targets:CHEMBL399, CLS:300194, Cosmic:760219, Cosmic:760490, Cosmic:801357, Cosmic:809231, Cosmic:877477, Cosmic:911999, Cosmic:925354, Cosmic:928907, Cosmic:944113, Cosmic:1019309, Cosmic:1057766, Cosmic:1071911, Cosmic:1131525, Cosmic:1193029, Cosmic:1201779, Cosmic:1324208, Cosmic:1336880, Cosmic:1571796, Cosmic:2301539, Cosmic:2660190, Cosmic:2750874, Cosmic:2791019, Cosmic:2816214, Cosmic-CLP:1298134, dbGAP:phs000640.v4.p1, DepMap:ACH-001086, DSMZ:ACC-57, DSMZCellDive:ACC-57, ECACC:93021013, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:phs000640, FCS-free:44-2-47-1-8-9, GDSC:1298134, GEO:GSM113863, GEO:GSM226739, GEO:GSM226875, GEO:GSM253298, GEO:GSM436128, GEO:GSM436129, GEO:GSM501788, GEO:GSM722574, GEO:GSM722575, GEO:GSM723055, GEO:GSM723056, GEO:GSM1088663, GEO:GSM1088664, GEO:GSM1088665, GEO:GSM1088666, GEO:GSM1374528, GEO:GSM1669875, GEO:GSM1881473, GEO:GSM1881474, GEO:GSM1881475, GEO:GSM7701367, GEO:GSM7701368, Hysigen:TCH-C193, ICLC:HTL95023, IGRhCellID:HeLA, IZSLER:BS TCL 20, JCRB:JCRB9004, KCB:KCB 86019YJ, KCB:KCB 90024YJ, KCLB:10002, LINCS_HMS:50061, LINCS_LDP:LCL-1512, Lonza:51, MeSH:D006367, NCBI_Iran:C115, PharmacoDB:HeLa_536_2019, PRIDE:PRD000007, PRIDE:PRD000032, PRIDE:PRD000123, PRIDE:PRD000124, PRIDE:PRD000345, PRIDE:PRD000376, PRIDE:PRD000525, PRIDE:PRD000526, PRIDE:PRD000527, PRIDE:PXD000013, PRIDE:PXD000243, PRIDE:PXD000252, PRIDE:PXD000279, PRIDE:PXD000396, PRIDE:PXD000474, PRIDE:PXD000589, PRIDE:PXD000661, PRIDE:PXD000680, PRIDE:PXD000759, PRIDE:PXD000883, PRIDE:PXD000895, PRIDE:PXD000900, PRIDE:PXD000953, PRIDE:PXD000954, PRIDE:PXD000999, PRIDE:PXD001047, PRIDE:PXD001118, PRIDE:PXD001154, PRIDE:PXD001175, PRIDE:PXD001249, PRIDE:PXD001258, PRIDE:PXD001259, PRIDE:PXD001278, PRIDE:PXD001305, PRIDE:PXD001374, PRIDE:PXD001381, PRIDE:PXD001396, PRIDE:PXD001441, PRIDE:PXD001541, PRIDE:PXD001548, PRIDE:PXD001574, PRIDE:PXD001660, PRIDE:PXD001781, PRIDE:PXD001798, PRIDE:PXD001805, PRIDE:PXD001806, PRIDE:PXD001810, PRIDE:PXD001863, PRIDE:PXD001907, PRIDE:PXD002001, PRIDE:PXD002039, PRIDE:PXD002066, PRIDE:PXD002252, PRIDE:PXD002277, PRIDE:PXD002378, PRIDE:PXD002383, PRIDE:PXD002395, PRIDE:PXD002572, PRIDE:PXD002591, PRIDE:PXD002704, PRIDE:PXD002844, PRIDE:PXD002880, PRIDE:PXD003186, PRIDE:PXD003209, PRIDE:PXD003258, PRIDE:PXD003370, PRIDE:PXD003503, PRIDE:PXD003530, PRIDE:PXD003560, PRIDE:PXD003792, PRIDE:PXD003813, PRIDE:PXD003909, PRIDE:PXD003913, PRIDE:PXD003917, PRIDE:PXD003924, PRIDE:PXD004182, PRIDE:PXD004271, PRIDE:PXD004273, PRIDE:PXD004452, PRIDE:PXD004613, PRIDE:PXD004736, PRIDE:PXD004900, PRIDE:PXD004914, PRIDE:PXD004933, PRIDE:PXD004934, PRIDE:PXD004940, PRIDE:PXD004995, PRIDE:PXD005018, PRIDE:PXD005107, PRIDE:PXD005181, PRIDE:PXD005346, PRIDE:PXD005349, PRIDE:PXD005366, PRIDE:PXD005466, PRIDE:PXD005509, PRIDE:PXD005572, PRIDE:PXD005712, PRIDE:PXD005955, PRIDE:PXD006112, PRIDE:PXD006293, PRIDE:PXD012045, PRIDE:PXD012188, PRIDE:PXD013064, PRIDE:PXD023271, PRIDE:PXD023835, PRIDE:PXD027504, PRIDE:PXD029773, PRIDE:PXD030304, Progenetix:CVCL_0030, PubChem_Cell_line:CVCL_0030, RCB:RCB0007, RCB:RCB3680, SKY/M-FISH/CGH:5351, TKG:TKG 0331, TOKU-E:1434, Ubigene:YC-A012, Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-09-12 05:40:14 |
39236 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
Abcam Cat# ab260075, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569 PMID:1246620 PMID:1522048 PMID:2983228 PMID:2990217 PMID:3028716 PMID:3180844 PMID:3371749 PMID:3518877 PMID:4942173 PMID:5668122 PMID:6256643 PMID:6358339 PMID:6401685 PMID:6825208 PMID:6935474 PMID:8380785 PMID:9892199 PMID:10423141 PMID:11416159 PMID:11668190 PMID:12001993 PMID:12661003 PMID:12793746 PMID:13052828 PMID:13207312 PMID:13261081 PMID:14031339 PMID:14185313 PMID:15302935 PMID:15531914 PMID:15901131 PMID:16589695 PMID:16957166 PMID:17311676 PMID:19450234 PMID:19722756 PMID:19941903 PMID:21269460 PMID:21937730 PMID:22068331 PMID:22278370 PMID:22412903 PMID:23205564 PMID:23336012 PMID:23925224 PMID:23925245 PMID:24134916 PMID:24618588 PMID:24696503 PMID:24908793 PMID:25485619 PMID:25807930 PMID:25877200 PMID:25894527 PMID:25960936 PMID:26554430 PMID:26589293 PMID:27397505 PMID:28078501 PMID:28196595 PMID:28261610 PMID:28601559 PMID:29156801 PMID:30175587 PMID:30778230 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31433507 PMID:31790455 PMID:33389257 PMID:35198691 PMID:35839778 PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
Abcam |
ab260075 |
BTO:BTO_0000567, CLO:CLO_0003684, CLO:CLO_0050910, EFO:EFO_0001185, MCCL:MCC:0000219, CLDB:cl1594, CLDB:cl1595, CLDB:cl1596, CLDB:cl1597, CLDB:cl1599, CLDB:cl1600, CLDB:cl1601, CLDB:cl1603, Abcam:ab255448, Abcam:ab255928, Abcam:ab260075, Abcam:ab271142, Abcam:ab275466, AddexBio:C0008001/44, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CCL-2, ATCC:CRL-7923, ATCC:CRM-CCL-2, BCRC:60005, BCRJ:0100, BEI_Resources:ARP-153, BioGRID_ORCS_Cell_line:95, BioSample:SAMN03471148, BioSample:SAMN03472333, BioSample:SAMN10989629, cancercelllines:CVCL_0030, CCLV:CCLV-RIE 0082, CCRID:1101HUM-PUMC000011, CCRID:1101HUM-PUMC000332, CCRID:1102HUM-NIFDC00057, CCRID:3101HUMSCSP504, CCRID:3101HUMTCHu187, CCRID:4201HUM-CCTCC00009, CCRID:5301HUM-KCB90024YJ, CCTCC:GDC0009, Cell_Model_Passport:SIDM00846, ChEMBL-Cells:CHEMBL3308376, ChEMBL-Targets:CHEMBL399, CLS:300194, Cosmic:760219, Cosmic:760490, Cosmic:801357, Cosmic:809231, Cosmic:877477, Cosmic:911999, Cosmic:925354, Cosmic:928907, Cosmic:944113, Cosmic:1019309, Cosmic:1057766, Cosmic:1071911, Cosmic:1131525, Cosmic:1193029, Cosmic:1201779, Cosmic:1324208, Cosmic:1336880, Cosmic:1571796, Cosmic:2301539, Cosmic:2660190, Cosmic:2750874, Cosmic:2791019, Cosmic:2816214, Cosmic-CLP:1298134, dbGAP:phs000640.v4.p1, DepMap:ACH-001086, DSMZ:ACC-57, DSMZCellDive:ACC-57, ECACC:93021013, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:phs000640, FCS-free:44-2-47-1-8-9, GDSC:1298134, GEO:GSM113863, GEO:GSM226739, GEO:GSM226875, GEO:GSM253298, GEO:GSM436128, GEO:GSM436129, GEO:GSM501788, GEO:GSM722574, GEO:GSM722575, GEO:GSM723055, GEO:GSM723056, GEO:GSM1088663, GEO:GSM1088664, GEO:GSM1088665, GEO:GSM1088666, GEO:GSM1374528, GEO:GSM1669875, GEO:GSM1881473, GEO:GSM1881474, GEO:GSM1881475, GEO:GSM7701367, GEO:GSM7701368, Hysigen:TCH-C193, ICLC:HTL95023, IGRhCellID:HeLA, IZSLER:BS TCL 20, JCRB:JCRB9004, KCB:KCB 86019YJ, KCB:KCB 90024YJ, KCLB:10002, LINCS_HMS:50061, LINCS_LDP:LCL-1512, Lonza:51, MeSH:D006367, NCBI_Iran:C115, PharmacoDB:HeLa_536_2019, PRIDE:PRD000007, PRIDE:PRD000032, PRIDE:PRD000123, PRIDE:PRD000124, PRIDE:PRD000345, PRIDE:PRD000376, PRIDE:PRD000525, PRIDE:PRD000526, PRIDE:PRD000527, PRIDE:PXD000013, PRIDE:PXD000243, PRIDE:PXD000252, PRIDE:PXD000279, PRIDE:PXD000396, PRIDE:PXD000474, PRIDE:PXD000589, PRIDE:PXD000661, PRIDE:PXD000680, PRIDE:PXD000759, PRIDE:PXD000883, PRIDE:PXD000895, PRIDE:PXD000900, PRIDE:PXD000953, PRIDE:PXD000954, PRIDE:PXD000999, PRIDE:PXD001047, PRIDE:PXD001118, PRIDE:PXD001154, PRIDE:PXD001175, PRIDE:PXD001249, PRIDE:PXD001258, PRIDE:PXD001259, PRIDE:PXD001278, PRIDE:PXD001305, PRIDE:PXD001374, PRIDE:PXD001381, PRIDE:PXD001396, PRIDE:PXD001441, PRIDE:PXD001541, PRIDE:PXD001548, PRIDE:PXD001574, PRIDE:PXD001660, PRIDE:PXD001781, PRIDE:PXD001798, PRIDE:PXD001805, PRIDE:PXD001806, PRIDE:PXD001810, PRIDE:PXD001863, PRIDE:PXD001907, PRIDE:PXD002001, PRIDE:PXD002039, PRIDE:PXD002066, PRIDE:PXD002252, PRIDE:PXD002277, PRIDE:PXD002378, PRIDE:PXD002383, PRIDE:PXD002395, PRIDE:PXD002572, PRIDE:PXD002591, PRIDE:PXD002704, PRIDE:PXD002844, PRIDE:PXD002880, PRIDE:PXD003186, PRIDE:PXD003209, PRIDE:PXD003258, PRIDE:PXD003370, PRIDE:PXD003503, PRIDE:PXD003530, PRIDE:PXD003560, PRIDE:PXD003792, PRIDE:PXD003813, PRIDE:PXD003909, PRIDE:PXD003913, PRIDE:PXD003917, PRIDE:PXD003924, PRIDE:PXD004182, PRIDE:PXD004271, PRIDE:PXD004273, PRIDE:PXD004452, PRIDE:PXD004613, PRIDE:PXD004736, PRIDE:PXD004900, PRIDE:PXD004914, PRIDE:PXD004933, PRIDE:PXD004934, PRIDE:PXD004940, PRIDE:PXD004995, PRIDE:PXD005018, PRIDE:PXD005107, PRIDE:PXD005181, PRIDE:PXD005346, PRIDE:PXD005349, PRIDE:PXD005366, PRIDE:PXD005466, PRIDE:PXD005509, PRIDE:PXD005572, PRIDE:PXD005712, PRIDE:PXD005955, PRIDE:PXD006112, PRIDE:PXD006293, PRIDE:PXD012045, PRIDE:PXD012188, PRIDE:PXD013064, PRIDE:PXD023271, PRIDE:PXD023835, PRIDE:PXD027504, PRIDE:PXD029773, PRIDE:PXD030304, Progenetix:CVCL_0030, PubChem_Cell_line:CVCL_0030, RCB:RCB0007, RCB:RCB3680, SKY/M-FISH/CGH:5351, TKG:TKG 0331, TOKU-E:1434, Ubigene:YC-A012, Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-09-12 05:40:14 |
39236 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
JCRB Cat# JCRB9004, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569 PMID:1246620 PMID:1522048 PMID:2983228 PMID:2990217 PMID:3028716 PMID:3180844 PMID:3371749 PMID:3518877 PMID:4942173 PMID:5668122 PMID:6256643 PMID:6358339 PMID:6401685 PMID:6825208 PMID:6935474 PMID:8380785 PMID:9892199 PMID:10423141 PMID:11416159 PMID:11668190 PMID:12001993 PMID:12661003 PMID:12793746 PMID:13052828 PMID:13207312 PMID:13261081 PMID:14031339 PMID:14185313 PMID:15302935 PMID:15531914 PMID:15901131 PMID:16589695 PMID:16957166 PMID:17311676 PMID:19450234 PMID:19722756 PMID:19941903 PMID:21269460 PMID:21937730 PMID:22068331 PMID:22278370 PMID:22412903 PMID:23205564 PMID:23336012 PMID:23925224 PMID:23925245 PMID:24134916 PMID:24618588 PMID:24696503 PMID:24908793 PMID:25485619 PMID:25807930 PMID:25877200 PMID:25894527 PMID:25960936 PMID:26554430 PMID:26589293 PMID:27397505 PMID:28078501 PMID:28196595 PMID:28261610 PMID:28601559 PMID:29156801 PMID:30175587 PMID:30778230 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31433507 PMID:31790455 PMID:33389257 PMID:35198691 PMID:35839778 PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
JCRB |
JCRB9004 |
BTO:BTO_0000567, CLO:CLO_0003684, CLO:CLO_0050910, EFO:EFO_0001185, MCCL:MCC:0000219, CLDB:cl1594, CLDB:cl1595, CLDB:cl1596, CLDB:cl1597, CLDB:cl1599, CLDB:cl1600, CLDB:cl1601, CLDB:cl1603, Abcam:ab255448, Abcam:ab255928, Abcam:ab260075, Abcam:ab271142, Abcam:ab275466, AddexBio:C0008001/44, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CCL-2, ATCC:CRL-7923, ATCC:CRM-CCL-2, BCRC:60005, BCRJ:0100, BEI_Resources:ARP-153, BioGRID_ORCS_Cell_line:95, BioSample:SAMN03471148, BioSample:SAMN03472333, BioSample:SAMN10989629, cancercelllines:CVCL_0030, CCLV:CCLV-RIE 0082, CCRID:1101HUM-PUMC000011, CCRID:1101HUM-PUMC000332, CCRID:1102HUM-NIFDC00057, CCRID:3101HUMSCSP504, CCRID:3101HUMTCHu187, CCRID:4201HUM-CCTCC00009, CCRID:5301HUM-KCB90024YJ, CCTCC:GDC0009, Cell_Model_Passport:SIDM00846, ChEMBL-Cells:CHEMBL3308376, ChEMBL-Targets:CHEMBL399, CLS:300194, Cosmic:760219, Cosmic:760490, Cosmic:801357, Cosmic:809231, Cosmic:877477, Cosmic:911999, Cosmic:925354, Cosmic:928907, Cosmic:944113, Cosmic:1019309, Cosmic:1057766, Cosmic:1071911, Cosmic:1131525, Cosmic:1193029, Cosmic:1201779, Cosmic:1324208, Cosmic:1336880, Cosmic:1571796, Cosmic:2301539, Cosmic:2660190, Cosmic:2750874, Cosmic:2791019, Cosmic:2816214, Cosmic-CLP:1298134, dbGAP:phs000640.v4.p1, DepMap:ACH-001086, DSMZ:ACC-57, DSMZCellDive:ACC-57, ECACC:93021013, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:phs000640, FCS-free:44-2-47-1-8-9, GDSC:1298134, GEO:GSM113863, GEO:GSM226739, GEO:GSM226875, GEO:GSM253298, GEO:GSM436128, GEO:GSM436129, GEO:GSM501788, GEO:GSM722574, GEO:GSM722575, GEO:GSM723055, GEO:GSM723056, GEO:GSM1088663, GEO:GSM1088664, GEO:GSM1088665, GEO:GSM1088666, GEO:GSM1374528, GEO:GSM1669875, GEO:GSM1881473, GEO:GSM1881474, GEO:GSM1881475, GEO:GSM7701367, GEO:GSM7701368, Hysigen:TCH-C193, ICLC:HTL95023, IGRhCellID:HeLA, IZSLER:BS TCL 20, JCRB:JCRB9004, KCB:KCB 86019YJ, KCB:KCB 90024YJ, KCLB:10002, LINCS_HMS:50061, LINCS_LDP:LCL-1512, Lonza:51, MeSH:D006367, NCBI_Iran:C115, PharmacoDB:HeLa_536_2019, PRIDE:PRD000007, PRIDE:PRD000032, PRIDE:PRD000123, PRIDE:PRD000124, PRIDE:PRD000345, PRIDE:PRD000376, PRIDE:PRD000525, PRIDE:PRD000526, PRIDE:PRD000527, PRIDE:PXD000013, PRIDE:PXD000243, PRIDE:PXD000252, PRIDE:PXD000279, PRIDE:PXD000396, PRIDE:PXD000474, PRIDE:PXD000589, PRIDE:PXD000661, PRIDE:PXD000680, PRIDE:PXD000759, PRIDE:PXD000883, PRIDE:PXD000895, PRIDE:PXD000900, PRIDE:PXD000953, PRIDE:PXD000954, PRIDE:PXD000999, PRIDE:PXD001047, PRIDE:PXD001118, PRIDE:PXD001154, PRIDE:PXD001175, PRIDE:PXD001249, PRIDE:PXD001258, PRIDE:PXD001259, PRIDE:PXD001278, PRIDE:PXD001305, PRIDE:PXD001374, PRIDE:PXD001381, PRIDE:PXD001396, PRIDE:PXD001441, PRIDE:PXD001541, PRIDE:PXD001548, PRIDE:PXD001574, PRIDE:PXD001660, PRIDE:PXD001781, PRIDE:PXD001798, PRIDE:PXD001805, PRIDE:PXD001806, PRIDE:PXD001810, PRIDE:PXD001863, PRIDE:PXD001907, PRIDE:PXD002001, PRIDE:PXD002039, PRIDE:PXD002066, PRIDE:PXD002252, PRIDE:PXD002277, PRIDE:PXD002378, PRIDE:PXD002383, PRIDE:PXD002395, PRIDE:PXD002572, PRIDE:PXD002591, PRIDE:PXD002704, PRIDE:PXD002844, PRIDE:PXD002880, PRIDE:PXD003186, PRIDE:PXD003209, PRIDE:PXD003258, PRIDE:PXD003370, PRIDE:PXD003503, PRIDE:PXD003530, PRIDE:PXD003560, PRIDE:PXD003792, PRIDE:PXD003813, PRIDE:PXD003909, PRIDE:PXD003913, PRIDE:PXD003917, PRIDE:PXD003924, PRIDE:PXD004182, PRIDE:PXD004271, PRIDE:PXD004273, PRIDE:PXD004452, PRIDE:PXD004613, PRIDE:PXD004736, PRIDE:PXD004900, PRIDE:PXD004914, PRIDE:PXD004933, PRIDE:PXD004934, PRIDE:PXD004940, PRIDE:PXD004995, PRIDE:PXD005018, PRIDE:PXD005107, PRIDE:PXD005181, PRIDE:PXD005346, PRIDE:PXD005349, PRIDE:PXD005366, PRIDE:PXD005466, PRIDE:PXD005509, PRIDE:PXD005572, PRIDE:PXD005712, PRIDE:PXD005955, PRIDE:PXD006112, PRIDE:PXD006293, PRIDE:PXD012045, PRIDE:PXD012188, PRIDE:PXD013064, PRIDE:PXD023271, PRIDE:PXD023835, PRIDE:PXD027504, PRIDE:PXD029773, PRIDE:PXD030304, Progenetix:CVCL_0030, PubChem_Cell_line:CVCL_0030, RCB:RCB0007, RCB:RCB3680, SKY/M-FISH/CGH:5351, TKG:TKG 0331, TOKU-E:1434, Ubigene:YC-A012, Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-09-12 05:40:14 |
39236 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
BCRC Cat# 60005, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569 PMID:1246620 PMID:1522048 PMID:2983228 PMID:2990217 PMID:3028716 PMID:3180844 PMID:3371749 PMID:3518877 PMID:4942173 PMID:5668122 PMID:6256643 PMID:6358339 PMID:6401685 PMID:6825208 PMID:6935474 PMID:8380785 PMID:9892199 PMID:10423141 PMID:11416159 PMID:11668190 PMID:12001993 PMID:12661003 PMID:12793746 PMID:13052828 PMID:13207312 PMID:13261081 PMID:14031339 PMID:14185313 PMID:15302935 PMID:15531914 PMID:15901131 PMID:16589695 PMID:16957166 PMID:17311676 PMID:19450234 PMID:19722756 PMID:19941903 PMID:21269460 PMID:21937730 PMID:22068331 PMID:22278370 PMID:22412903 PMID:23205564 PMID:23336012 PMID:23925224 PMID:23925245 PMID:24134916 PMID:24618588 PMID:24696503 PMID:24908793 PMID:25485619 PMID:25807930 PMID:25877200 PMID:25894527 PMID:25960936 PMID:26554430 PMID:26589293 PMID:27397505 PMID:28078501 PMID:28196595 PMID:28261610 PMID:28601559 PMID:29156801 PMID:30175587 PMID:30778230 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31433507 PMID:31790455 PMID:33389257 PMID:35198691 PMID:35839778 PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
BCRC |
60005 |
BTO:BTO_0000567, CLO:CLO_0003684, CLO:CLO_0050910, EFO:EFO_0001185, MCCL:MCC:0000219, CLDB:cl1594, CLDB:cl1595, CLDB:cl1596, CLDB:cl1597, CLDB:cl1599, CLDB:cl1600, CLDB:cl1601, CLDB:cl1603, Abcam:ab255448, Abcam:ab255928, Abcam:ab260075, Abcam:ab271142, Abcam:ab275466, AddexBio:C0008001/44, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CCL-2, ATCC:CRL-7923, ATCC:CRM-CCL-2, BCRC:60005, BCRJ:0100, BEI_Resources:ARP-153, BioGRID_ORCS_Cell_line:95, BioSample:SAMN03471148, BioSample:SAMN03472333, BioSample:SAMN10989629, cancercelllines:CVCL_0030, CCLV:CCLV-RIE 0082, CCRID:1101HUM-PUMC000011, CCRID:1101HUM-PUMC000332, CCRID:1102HUM-NIFDC00057, CCRID:3101HUMSCSP504, CCRID:3101HUMTCHu187, CCRID:4201HUM-CCTCC00009, CCRID:5301HUM-KCB90024YJ, CCTCC:GDC0009, Cell_Model_Passport:SIDM00846, ChEMBL-Cells:CHEMBL3308376, ChEMBL-Targets:CHEMBL399, CLS:300194, Cosmic:760219, Cosmic:760490, Cosmic:801357, Cosmic:809231, Cosmic:877477, Cosmic:911999, Cosmic:925354, Cosmic:928907, Cosmic:944113, Cosmic:1019309, Cosmic:1057766, Cosmic:1071911, Cosmic:1131525, Cosmic:1193029, Cosmic:1201779, Cosmic:1324208, Cosmic:1336880, Cosmic:1571796, Cosmic:2301539, Cosmic:2660190, Cosmic:2750874, Cosmic:2791019, Cosmic:2816214, Cosmic-CLP:1298134, dbGAP:phs000640.v4.p1, DepMap:ACH-001086, DSMZ:ACC-57, DSMZCellDive:ACC-57, ECACC:93021013, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:phs000640, FCS-free:44-2-47-1-8-9, GDSC:1298134, GEO:GSM113863, GEO:GSM226739, GEO:GSM226875, GEO:GSM253298, GEO:GSM436128, GEO:GSM436129, GEO:GSM501788, GEO:GSM722574, GEO:GSM722575, GEO:GSM723055, GEO:GSM723056, GEO:GSM1088663, GEO:GSM1088664, GEO:GSM1088665, GEO:GSM1088666, GEO:GSM1374528, GEO:GSM1669875, GEO:GSM1881473, GEO:GSM1881474, GEO:GSM1881475, GEO:GSM7701367, GEO:GSM7701368, Hysigen:TCH-C193, ICLC:HTL95023, IGRhCellID:HeLA, IZSLER:BS TCL 20, JCRB:JCRB9004, KCB:KCB 86019YJ, KCB:KCB 90024YJ, KCLB:10002, LINCS_HMS:50061, LINCS_LDP:LCL-1512, Lonza:51, MeSH:D006367, NCBI_Iran:C115, PharmacoDB:HeLa_536_2019, PRIDE:PRD000007, PRIDE:PRD000032, PRIDE:PRD000123, PRIDE:PRD000124, PRIDE:PRD000345, PRIDE:PRD000376, PRIDE:PRD000525, PRIDE:PRD000526, PRIDE:PRD000527, PRIDE:PXD000013, PRIDE:PXD000243, PRIDE:PXD000252, PRIDE:PXD000279, PRIDE:PXD000396, PRIDE:PXD000474, PRIDE:PXD000589, PRIDE:PXD000661, PRIDE:PXD000680, PRIDE:PXD000759, PRIDE:PXD000883, PRIDE:PXD000895, PRIDE:PXD000900, PRIDE:PXD000953, PRIDE:PXD000954, PRIDE:PXD000999, PRIDE:PXD001047, PRIDE:PXD001118, PRIDE:PXD001154, PRIDE:PXD001175, PRIDE:PXD001249, PRIDE:PXD001258, PRIDE:PXD001259, PRIDE:PXD001278, PRIDE:PXD001305, PRIDE:PXD001374, PRIDE:PXD001381, PRIDE:PXD001396, PRIDE:PXD001441, PRIDE:PXD001541, PRIDE:PXD001548, PRIDE:PXD001574, PRIDE:PXD001660, PRIDE:PXD001781, PRIDE:PXD001798, PRIDE:PXD001805, PRIDE:PXD001806, PRIDE:PXD001810, PRIDE:PXD001863, PRIDE:PXD001907, PRIDE:PXD002001, PRIDE:PXD002039, PRIDE:PXD002066, PRIDE:PXD002252, PRIDE:PXD002277, PRIDE:PXD002378, PRIDE:PXD002383, PRIDE:PXD002395, PRIDE:PXD002572, PRIDE:PXD002591, PRIDE:PXD002704, PRIDE:PXD002844, PRIDE:PXD002880, PRIDE:PXD003186, PRIDE:PXD003209, PRIDE:PXD003258, PRIDE:PXD003370, PRIDE:PXD003503, PRIDE:PXD003530, PRIDE:PXD003560, PRIDE:PXD003792, PRIDE:PXD003813, PRIDE:PXD003909, PRIDE:PXD003913, PRIDE:PXD003917, PRIDE:PXD003924, PRIDE:PXD004182, PRIDE:PXD004271, PRIDE:PXD004273, PRIDE:PXD004452, PRIDE:PXD004613, PRIDE:PXD004736, PRIDE:PXD004900, PRIDE:PXD004914, PRIDE:PXD004933, PRIDE:PXD004934, PRIDE:PXD004940, PRIDE:PXD004995, PRIDE:PXD005018, PRIDE:PXD005107, PRIDE:PXD005181, PRIDE:PXD005346, PRIDE:PXD005349, PRIDE:PXD005366, PRIDE:PXD005466, PRIDE:PXD005509, PRIDE:PXD005572, PRIDE:PXD005712, PRIDE:PXD005955, PRIDE:PXD006112, PRIDE:PXD006293, PRIDE:PXD012045, PRIDE:PXD012188, PRIDE:PXD013064, PRIDE:PXD023271, PRIDE:PXD023835, PRIDE:PXD027504, PRIDE:PXD029773, PRIDE:PXD030304, Progenetix:CVCL_0030, PubChem_Cell_line:CVCL_0030, RCB:RCB0007, RCB:RCB3680, SKY/M-FISH/CGH:5351, TKG:TKG 0331, TOKU-E:1434, Ubigene:YC-A012, Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-09-12 05:40:14 |
39236 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
AddexBio Cat# C0008001/44, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569 PMID:1246620 PMID:1522048 PMID:2983228 PMID:2990217 PMID:3028716 PMID:3180844 PMID:3371749 PMID:3518877 PMID:4942173 PMID:5668122 PMID:6256643 PMID:6358339 PMID:6401685 PMID:6825208 PMID:6935474 PMID:8380785 PMID:9892199 PMID:10423141 PMID:11416159 PMID:11668190 PMID:12001993 PMID:12661003 PMID:12793746 PMID:13052828 PMID:13207312 PMID:13261081 PMID:14031339 PMID:14185313 PMID:15302935 PMID:15531914 PMID:15901131 PMID:16589695 PMID:16957166 PMID:17311676 PMID:19450234 PMID:19722756 PMID:19941903 PMID:21269460 PMID:21937730 PMID:22068331 PMID:22278370 PMID:22412903 PMID:23205564 PMID:23336012 PMID:23925224 PMID:23925245 PMID:24134916 PMID:24618588 PMID:24696503 PMID:24908793 PMID:25485619 PMID:25807930 PMID:25877200 PMID:25894527 PMID:25960936 PMID:26554430 PMID:26589293 PMID:27397505 PMID:28078501 PMID:28196595 PMID:28261610 PMID:28601559 PMID:29156801 PMID:30175587 PMID:30778230 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31433507 PMID:31790455 PMID:33389257 PMID:35198691 PMID:35839778 PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
AddexBio |
C0008001/44 |
BTO:BTO_0000567, CLO:CLO_0003684, CLO:CLO_0050910, EFO:EFO_0001185, MCCL:MCC:0000219, CLDB:cl1594, CLDB:cl1595, CLDB:cl1596, CLDB:cl1597, CLDB:cl1599, CLDB:cl1600, CLDB:cl1601, CLDB:cl1603, Abcam:ab255448, Abcam:ab255928, Abcam:ab260075, Abcam:ab271142, Abcam:ab275466, AddexBio:C0008001/44, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CCL-2, ATCC:CRL-7923, ATCC:CRM-CCL-2, BCRC:60005, BCRJ:0100, BEI_Resources:ARP-153, BioGRID_ORCS_Cell_line:95, BioSample:SAMN03471148, BioSample:SAMN03472333, BioSample:SAMN10989629, cancercelllines:CVCL_0030, CCLV:CCLV-RIE 0082, CCRID:1101HUM-PUMC000011, CCRID:1101HUM-PUMC000332, CCRID:1102HUM-NIFDC00057, CCRID:3101HUMSCSP504, CCRID:3101HUMTCHu187, CCRID:4201HUM-CCTCC00009, CCRID:5301HUM-KCB90024YJ, CCTCC:GDC0009, Cell_Model_Passport:SIDM00846, ChEMBL-Cells:CHEMBL3308376, ChEMBL-Targets:CHEMBL399, CLS:300194, Cosmic:760219, Cosmic:760490, Cosmic:801357, Cosmic:809231, Cosmic:877477, Cosmic:911999, Cosmic:925354, Cosmic:928907, Cosmic:944113, Cosmic:1019309, Cosmic:1057766, Cosmic:1071911, Cosmic:1131525, Cosmic:1193029, Cosmic:1201779, Cosmic:1324208, Cosmic:1336880, Cosmic:1571796, Cosmic:2301539, Cosmic:2660190, Cosmic:2750874, Cosmic:2791019, Cosmic:2816214, Cosmic-CLP:1298134, dbGAP:phs000640.v4.p1, DepMap:ACH-001086, DSMZ:ACC-57, DSMZCellDive:ACC-57, ECACC:93021013, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:phs000640, FCS-free:44-2-47-1-8-9, GDSC:1298134, GEO:GSM113863, GEO:GSM226739, GEO:GSM226875, GEO:GSM253298, GEO:GSM436128, GEO:GSM436129, GEO:GSM501788, GEO:GSM722574, GEO:GSM722575, GEO:GSM723055, GEO:GSM723056, GEO:GSM1088663, GEO:GSM1088664, GEO:GSM1088665, GEO:GSM1088666, GEO:GSM1374528, GEO:GSM1669875, GEO:GSM1881473, GEO:GSM1881474, GEO:GSM1881475, GEO:GSM7701367, GEO:GSM7701368, Hysigen:TCH-C193, ICLC:HTL95023, IGRhCellID:HeLA, IZSLER:BS TCL 20, JCRB:JCRB9004, KCB:KCB 86019YJ, KCB:KCB 90024YJ, KCLB:10002, LINCS_HMS:50061, LINCS_LDP:LCL-1512, Lonza:51, MeSH:D006367, NCBI_Iran:C115, PharmacoDB:HeLa_536_2019, PRIDE:PRD000007, PRIDE:PRD000032, PRIDE:PRD000123, PRIDE:PRD000124, PRIDE:PRD000345, PRIDE:PRD000376, PRIDE:PRD000525, PRIDE:PRD000526, PRIDE:PRD000527, PRIDE:PXD000013, PRIDE:PXD000243, PRIDE:PXD000252, PRIDE:PXD000279, PRIDE:PXD000396, PRIDE:PXD000474, PRIDE:PXD000589, PRIDE:PXD000661, PRIDE:PXD000680, PRIDE:PXD000759, PRIDE:PXD000883, PRIDE:PXD000895, PRIDE:PXD000900, PRIDE:PXD000953, PRIDE:PXD000954, PRIDE:PXD000999, PRIDE:PXD001047, PRIDE:PXD001118, PRIDE:PXD001154, PRIDE:PXD001175, PRIDE:PXD001249, PRIDE:PXD001258, PRIDE:PXD001259, PRIDE:PXD001278, PRIDE:PXD001305, PRIDE:PXD001374, PRIDE:PXD001381, PRIDE:PXD001396, PRIDE:PXD001441, PRIDE:PXD001541, PRIDE:PXD001548, PRIDE:PXD001574, PRIDE:PXD001660, PRIDE:PXD001781, PRIDE:PXD001798, PRIDE:PXD001805, PRIDE:PXD001806, PRIDE:PXD001810, PRIDE:PXD001863, PRIDE:PXD001907, PRIDE:PXD002001, PRIDE:PXD002039, PRIDE:PXD002066, PRIDE:PXD002252, PRIDE:PXD002277, PRIDE:PXD002378, PRIDE:PXD002383, PRIDE:PXD002395, PRIDE:PXD002572, PRIDE:PXD002591, PRIDE:PXD002704, PRIDE:PXD002844, PRIDE:PXD002880, PRIDE:PXD003186, PRIDE:PXD003209, PRIDE:PXD003258, PRIDE:PXD003370, PRIDE:PXD003503, PRIDE:PXD003530, PRIDE:PXD003560, PRIDE:PXD003792, PRIDE:PXD003813, PRIDE:PXD003909, PRIDE:PXD003913, PRIDE:PXD003917, PRIDE:PXD003924, PRIDE:PXD004182, PRIDE:PXD004271, PRIDE:PXD004273, PRIDE:PXD004452, PRIDE:PXD004613, PRIDE:PXD004736, PRIDE:PXD004900, PRIDE:PXD004914, PRIDE:PXD004933, PRIDE:PXD004934, PRIDE:PXD004940, PRIDE:PXD004995, PRIDE:PXD005018, PRIDE:PXD005107, PRIDE:PXD005181, PRIDE:PXD005346, PRIDE:PXD005349, PRIDE:PXD005366, PRIDE:PXD005466, PRIDE:PXD005509, PRIDE:PXD005572, PRIDE:PXD005712, PRIDE:PXD005955, PRIDE:PXD006112, PRIDE:PXD006293, PRIDE:PXD012045, PRIDE:PXD012188, PRIDE:PXD013064, PRIDE:PXD023271, PRIDE:PXD023835, PRIDE:PXD027504, PRIDE:PXD029773, PRIDE:PXD030304, Progenetix:CVCL_0030, PubChem_Cell_line:CVCL_0030, RCB:RCB0007, RCB:RCB3680, SKY/M-FISH/CGH:5351, TKG:TKG 0331, TOKU-E:1434, Ubigene:YC-A012, Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-09-12 05:40:14 |
39236 |